Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AK002 in Healthy Participants
NCT02859701
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
51
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
AK002
OTHER:
Placebo
Sponsor
Allakos Inc.